
Efficacy of rabeprazole (Razo®) in the treatment of various clinical variants of GERD: results from the GERBERA study
Author(s) -
В. В. Цуканов,
M. A. Cherepnin,
A. V. Vasyutin,
Yu.L. Tonkikh,
Э. В. Каспаров,
N. A. Maslennikova,
Н. В. Павлова
Publication year - 2022
Publication title -
medicinskij sovet
Language(s) - English
Resource type - Journals
eISSN - 2658-5790
pISSN - 2079-701X
DOI - 10.21518/2079-701x-2022-16-7-28-35
Subject(s) - gerd , nerd , medicine , heartburn , rabeprazole , esophagitis , reflux esophagitis , gastroenterology , reflux , quality of life (healthcare) , prospective cohort study , disease , proton pump inhibitor , nursing